Literature DB >> 15642542

Relation between free triiodothyronine/free thyroxine ratio, echocardiographic parameters and mortality in dilated cardiomyopathy.

Guliz Kozdag1, Dilek Ural, Ahmet Vural, Aysen Agacdiken, Goksel Kahraman, Tayfun Sahin, Ertan Ural, Baki Komsuoglu.   

Abstract

BACKGROUND: Abnormalities in thyroid function are frequent in patients with heart failure and are associated with increased mortality. However, the relation between thyroid hormone levels and echocardiographic parameters has not been investigated sufficiently. AIM: The aims of this study were to investigate the correlations of thyroid hormone levels with echocardiographic parameters and to evaluate their associations with subsequent mortality in a group of patients with dilated cardiomyopathy (DCMP).
METHODS: Serum levels of thyroid hormones were measured in 111 consecutive patients with DCMP (35 female, 76 male, mean age: 62+/-12 years). All patients underwent echocardiographic examination and were followed-up for a period of 12+/-8 months.
RESULTS: Twenty-three patients (21%) had abnormalities in thyroid function tests. Free triiodothyronine (fT3)/free thyroxine (fT4) ratio was significantly correlated with most of echocardiographic parameters, such as chamber diameters and ejection fraction. Sixteen patients (14%) died during the follow-up period; their fT3/fT4 ratio was significantly lower than the patients who survived (1.31+/-0.37 vs. 2.01+/-0.72, p<0.001). A fT3/fT4 ratio of <or=1.7 was associated with an increased risk of mortality (p<0.001), independent of other prognostic markers. Sensitivity, specificity, positive and negative predictivity of fT3/fT4 ratio <or=1.7 for cardiac mortality were 100%, 71%, 36% and 100%, respectively.
CONCLUSION: Determination of FT3/FT4 ratio may be a valuable and simple predictor for identification of patients with DCMP who are at high risk of subsequent mortality.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15642542     DOI: 10.1016/j.ejheart.2004.04.016

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  17 in total

1.  Triiodothyronine and brain natriuretic peptide: similar long-term prognostic values for chronic heart failure.

Authors:  Guliz Kozdag; Gokhan Ertas; Teoman Kilic; Eser Acar; Tayfun Sahin; Dilek Ural
Journal:  Tex Heart Inst J       Date:  2010

Review 2.  The role of thyroid hormone in the pathophysiology of heart failure: clinical evidence.

Authors:  E Galli; A Pingitore; G Iervasi
Journal:  Heart Fail Rev       Date:  2008-12-27       Impact factor: 4.214

3.  Thyroid Hormone Status in Sitosterolemia Is Modified by Ezetimibe.

Authors:  Rgia A Othman; Semone B Myrie; David Mymin; Jean-Baptiste Roullet; Andrea E DeBarber; Robert D Steiner; Peter J H Jones
Journal:  J Pediatr       Date:  2017-06-16       Impact factor: 4.406

4.  Editorial: Hypothyroidism and the Heart: Much More Than Meets the Eye.

Authors:  Ajay K Sharma; Sachin Shah; Sarju Ganatra; G Muqtada Chaudhry
Journal:  Methodist Debakey Cardiovasc J       Date:  2017 Oct-Dec

Review 5.  Thyroid Dysfunction and Heart Failure: Mechanisms and Associations.

Authors:  Hernando Vargas-Uricoechea; Anilza Bonelo-Perdomo
Journal:  Curr Heart Fail Rep       Date:  2017-02

6.  Effectiveness and Safety of Thyroid Hormone Therapy in Patients with Dilated Cardiomyopathy: A Systematic Review and Meta-analysis of RCTs.

Authors:  Xiaoai Chen; Yun Bao; Chunxia Shi; Limin Tian
Journal:  Am J Cardiovasc Drugs       Date:  2022-09-01       Impact factor: 3.283

7.  Thyroid hormone and cardiac disease: from basic concepts to clinical application.

Authors:  Iordanis Mourouzis; Francesca Forini; Constantinos Pantos; Giorgio Iervasi
Journal:  J Thyroid Res       Date:  2011-06-19

8.  Thyroid (dys)function in heart failure: is it a potential target for medical treatment?

Authors:  Alessandro Pingitore; Giorgio Iervasi
Journal:  Vasc Health Risk Manag       Date:  2005

9.  Relationship and prognostic importance of thyroid hormone and N-terminal pro-B-Type natriuretic peptide for patients after acute coronary syndromes: a longitudinal observational study.

Authors:  Julija Brozaitiene; Narseta Mickuviene; Aurelija Podlipskyte; Julius Burkauskas; Robertas Bunevicius
Journal:  BMC Cardiovasc Disord       Date:  2016-02-18       Impact factor: 2.298

10.  Usefulness of FT3 to FT4 Ratio to Predict Mortality in Euthyroid Patients With Prior Cardiovascular Events Undergoing PCI: Five-Year Findings From a Large Single-Center Cohort Study.

Authors:  Deshan Yuan; Sida Jia; Pei Zhu; Ce Zhang; Yue Liu; Ru Liu; Jingjing Xu; Xiaofang Tang; Xueyan Zhao; Runlin Gao; Yuejin Yang; Bo Xu; Zhan Gao; Jinqing Yuan
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-05       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.